Where are our imaging techniques lacking?
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD
The role of lifestyle intervention in the high risk patient
Motility-associated microglial proteins in Alzheimer’s disease and after Aβ42 immunotherapy
The powerful role of the patient in the U.S. POINTER study